{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:54:33Z","timestamp":1761008073100,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vascn.2014.10.006","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T05:39:59Z","timestamp":1414129199000},"page":"72-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: A pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates"],"prefix":"10.1016","volume":"72","author":[{"given":"Bruce P.","family":"Damiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk J.","family":"van der Linde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Van Deuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Somers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Lubomirski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ard","family":"Teisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Gallacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2014.10.006_bb0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/07853899908995886","article-title":"Autonomic mechanisms and sudden death after abrupt coronary occlusion","volume":"31","author":"Airaksinen","year":"1999","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.vascn.2014.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.CIR.81.3.1123","article-title":"CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology","volume":"81","author":"Akhtar","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2014.10.006_bb0015","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0002-9149(91)90308-8","article-title":"Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators","volume":"68","author":"Akiyama","year":"1991","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.1988.tb11444.x","article-title":"The effects of the novel anti-anginal compound RS 43285 on myocardial conduction in the anaesthetized dog","volume":"93","author":"Allely","year":"1988","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0025","first-page":"2213","article-title":"Current clinical perspectives on antiarrhythmic drug therapy","volume":"45","author":"Anderson","year":"1986","journal-title":"Federation Proceedings"},{"issue":"Suppl.","key":"10.1016\/j.vascn.2014.10.006_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1054\/jelc.2000.20321","article-title":"Cellular and ionic mechanisms responsible for the Brugada syndrome","volume":"33","author":"Antzelevitch","year":"2000","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.bjp.0700926","article-title":"Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation","volume":"120","author":"Aupetit","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1050-1738(01)00116-5","article-title":"Inherited sodium channelopathies: novel therapeutic and proarrhythmic molecular mechanisms","volume":"11","author":"Balser","year":"2001","journal-title":"Trends in Cardiovascular Medicine"},{"key":"10.1016\/j.vascn.2014.10.006_bb0045","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00045391-200311000-00013","article-title":"QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs","volume":"10","author":"Cubeddu","year":"2003","journal-title":"American Journal of Therapy"},{"key":"10.1016\/j.vascn.2014.10.006_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pharmthera.2013.04.008","article-title":"The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias","volume":"139","author":"Curtis","year":"2013","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2014.10.006_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cardiores.2004.01.033","article-title":"Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis","volume":"62","author":"De Groot","year":"2004","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2014.10.006_bb0060","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/01.CIR.94.7.1592","article-title":"Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans","volume":"94","author":"Demolis","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2014.10.006_bb0065","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1540-8159.1997.tb05501.x","article-title":"Cellular and pathophysiological mechanisms of ventricular arrhythmias in acute ischemia and infarction","volume":"20","author":"Ehlert","year":"1997","journal-title":"Pacing and Clinical Electrophysiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0070","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9149(77)80164-1","article-title":"Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs","volume":"39","author":"Elharrar","year":"1977","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2012.00006","article-title":"Cardiac safety implications of hNav1.5 blockade and a framework for Pre-clinical evaluation","volume":"3","author":"Erdemli","year":"2012","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005344-200203000-00013","article-title":"Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat hearts","volume":"39","author":"Farkas","year":"2002","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.hrthm.2004.03.061","article-title":"Role of sodium and calcium channel block in unmasking the Brugada syndrome","volume":"1","author":"Fish","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2014.10.006_bb0090","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1476-5381.2011.01433.x","article-title":"The \u2018overly-sensitive\u2019 heart: sodium channel block and QRS interval prolongation","volume":"164","author":"Gintant","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/hrt.74.6.631","article-title":"Interaction of ischaemia and encainide\/flecainide treatment: a proposed mechanism for the increased mortality in CAST I","volume":"74","author":"Greenberg","year":"1995","journal-title":"British Heart Journal"},{"key":"10.1016\/j.vascn.2014.10.006_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na(+) channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0105","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/bjp.2008.275","article-title":"The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys","volume":"154","author":"Haushalter","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","article-title":"The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology","volume":"47","author":"Haverkamp","year":"2000","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2014.10.006_bb0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3565(25)20970-3","article-title":"Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion","volume":"279","author":"Heisler","year":"1996","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"Suppl. 2","key":"10.1016\/j.vascn.2014.10.006_bb0120","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.2337\/dc11-s202","article-title":"Impact of the U.S. Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugs","volume":"34","author":"Hirshberg","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vascn.2014.10.006_bb0125","first-page":"233","article-title":"Attenuation of conduction delay by ischemic preconditioning reduces ischemia-induced ventricular arrhythmias","volume":"53","author":"Hong","year":"1999","journal-title":"Acta Medica Okayama"},{"key":"10.1016\/j.vascn.2014.10.006_bb0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF02769184","article-title":"Structure, function and expression of voltage-dependent sodium channels","volume":"7","author":"Kallen","year":"1993","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0135","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00005344-199410000-00007","article-title":"Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes","volume":"24","author":"Kiehn","year":"1994","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0140","doi-asserted-by":"crossref","first-page":"1B","DOI":"10.1016\/0002-9149(84)90493-4","article-title":"Electrophysiologic basis for arrhythmias in ischemic heart disease","volume":"53","author":"Lazzara","year":"1984","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005344-198913040-00005","article-title":"Effects of flecainide on occlusion and reperfusion arrhythmias in dogs","volume":"13","author":"Lederman","year":"1989","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005344-199102000-00009","article-title":"Effects of quinidine on arrhythmias and conduction in an isolated tissue model of ischemia and reperfusion","volume":"17","author":"Li","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1476-5381.2010.00646.x","article-title":"Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers","volume":"160","author":"Lu","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bjp.2008.191","article-title":"Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines","volume":"154","author":"Lu","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0165","doi-asserted-by":"crossref","first-page":"89B","DOI":"10.1016\/0002-9149(84)90509-5","article-title":"Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram","volume":"53","author":"Morganroth","year":"1984","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0170","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0008-6363(97)00293-9","article-title":"Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs","volume":"37","author":"Nattel","year":"1998","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2014.10.006_bb0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/cvr\/15.2.80","article-title":"Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog","volume":"15","author":"Nattel","year":"1981","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2014.10.006_bb0180","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/bjp.2008.280","article-title":"Principles of safety pharmacology","volume":"154","author":"Pugsley","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vascn.2013.03.005","article-title":"A history of the role of the hERG channel in cardiac risk assessment","volume":"68","author":"Rampe","year":"2013","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2014.10.006_bb0190","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/01.CIR.92.5.1300","article-title":"Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs","volume":"92","author":"Ranger","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2014.10.006_bb0195","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.79.5.1000","article-title":"Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade","volume":"79","author":"Ranger","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2014.10.006_bb0200","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vascn.2014.10.006_bb0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.CIR.101.1.86","article-title":"Electrophysiological effects of dofetilide in an in vitro model of \"border zone\" between normal and ischemic\/reperfused myocardium","volume":"101","author":"Rouet","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2014.10.006_bb0210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/hrt.42.1.88","article-title":"Transmembrane potential changes and ventricular fibrillation during repetitive myocardial ischaemia in the dog","volume":"42","author":"Russell","year":"1979","journal-title":"British Heart Journal"},{"key":"10.1016\/j.vascn.2014.10.006_bb0215","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0735-1097(94)90380-8","article-title":"Ischemia enhances use-dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent","volume":"23","author":"Sadanaga","year":"1994","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0220","first-page":"3","article-title":"Mechanisms of ventricular arrhythmias in acute ischemia and reperfusion","volume":"22","author":"Sedlis","year":"1992","journal-title":"Cardiovascular Clinics"},{"key":"10.1016\/j.vascn.2014.10.006_bb0225","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00002018-200730120-00003","article-title":"Cardiac repolarisation and drug regulation: assessing cardiac safety 10years after the CPMP guidance","volume":"30","author":"Shah","year":"2007","journal-title":"Drug Safety"},{"key":"10.1016\/j.vascn.2014.10.006_bb0230","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0002-8703(94)90597-5","article-title":"Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system","volume":"128","author":"Stramba-Badiale","year":"1994","journal-title":"American Heart Journal"},{"key":"10.1016\/j.vascn.2014.10.006_bb0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1026574911150","article-title":"Proarrhythmia related to sodium channel blockade II: Postulated mechanisms of Brugada syndrome and their possible involvement in Class IC drug-induced ventricular arrhythmias during ischemia","volume":"4","author":"Tan","year":"2000","journal-title":"Cardiac Electrophysiology Review"},{"key":"10.1016\/j.vascn.2014.10.006_bb0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","author":"Van de Water","year":"1989","journal-title":"Journal of Pharmacological Methods"},{"key":"10.1016\/j.vascn.2014.10.006_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2009.04.195","article-title":"The fentanyl\/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research","volume":"60","author":"Van Deuren","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2014.10.006_bb0250","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1161\/01.CIR.89.6.2870","article-title":"Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis","volume":"89","author":"Villemaire","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2014.10.006_bb0255","first-page":"H1588","article-title":"pH dependence of kinetics and steady-state block of cardiac sodium channels by lidocaine","volume":"264","author":"Wendt","year":"1993","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.vascn.2014.10.006_bb0260","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1009915413034","article-title":"Proarrhythmia related to sodium channel blockade: Mechanisms, monitoring, prevention and management","volume":"2","author":"Wilde","year":"1998","journal-title":"Cardiac Electrophysiology Review"},{"key":"10.1016\/j.vascn.2014.10.006_bb0265","first-page":"H66","article-title":"Ischemic preconditioning: antiarrhythmic effects and electrophysiological mechanisms in isolated ventricle","volume":"274","author":"Zhu","year":"1998","journal-title":"The American Journal of Physiology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871914002767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871914002767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:59:09Z","timestamp":1761004749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871914002767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":53,"alternative-id":["S1056871914002767"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2014.10.006","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: A pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2014.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}